US Lucentis Competition Expectations Upended By Byooviz

Ranibizumab Biosimilar Competition Had Been Expected By End Of 2021 In US

 
• By David Wallace
2021 2022 Roll Over Wooden Blocks
Biosimilar competition to Lucentis has rolled over to 2022 • Source: Alamy

More from Biosimilars

More from Products